Boimel PJ, et al. – The experts examined the efficacy and safety of proton beam reirradiation (PRT) for the management of locally recurrent pancreatic adenocarcinoma. Their findings revealed that PRT was well tolerated, resulted in prolonged clinical outcomes compared to historical controls. Hence, this approach should be considered as a treatment option with concurrent chemotherapy in selected patients with locally–recurrent pancreatic cancer.